CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2017 to Q2 2021

Type / Class: Equity / COM
Symbol: CBPO

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2021 Q2	0	$0	-$1,735,291,952	$0	$0		0
2021 Q1	14,694,888	$1,739,831,314	+$59,909,606	$450,000	$12,752,000	$118.41	86
2020 Q4	14,203,755	$1,677,525,286	+$26,820,727	$898,000	$8,268,000	$118.11	87
2020 Q3	13,996,473	$1,555,378,737	+$76,084,134	$2,289,000	$19,960,000	$111.14	86
2020 Q2	13,287,734	$1,357,740,783	+$171,285,598	$2,115,000	$20,579,000	$102.18	87
2020 Q1	11,962,217	$1,291,071,310	+$93,726,516	$5,148,000	$28,559,000	$107.93	83
2019 Q4	11,064,933	$1,287,583,027	-$521,511,577	$8,728,000	$27,175,000	$116.38	85
2019 Q3	15,618,592	$1,787,858,029	+$78,290,656	$17,069,000	$14,714,000	$114.47	87
2019 Q2	14,927,088	$1,422,532,387	+$61,456,276	$9,998,000	$17,840,000	$95.30	70
2019 Q1	14,291,272	$1,304,124,623	-$29,166,527	$7,766,000	$18,799,000	$91.25	68
2018 Q4	14,663,282	$1,113,099,854	-$435,973,761	$7,630,000	$6,347,000	$75.91	65
2018 Q3	17,415,139	$1,393,009,230	+$180,616,339	$15,376,000	$7,496,000	$80.00	81
2018 Q2	14,942,553	$1,484,032,429	-$314,176,816	$6,943,000	$6,557,000	$99.33	89
2018 Q1	18,204,333	$1,475,380,731	-$6,542,188	$7,315,000	$2,422,000	$81.00	83
2017 Q4	18,327,997	$1,443,766,940	+$74,576,269	$6,105,000	$386,000	$78.77	89
2017 Q3	17,066,917	$1,574,456,699	+$1,182,605,228	$2,723,000	$2,611,000	$92.27	86
2017 Q2	4,074,912	$460,872,000	+$460,872,000			$113.09	4